uniQure N.V. QURE
23.03 USD -0.84 (-3.52%)
At closeNov 5, 2026, 7:00 AM EST
22.52 -0.51 -2.21%
Pre-market · Nov 5, 7:00 AM ET
21.51 Day range 24.22
8.73 52-week range 51.72
- YTD
- -3.76%
- 1 year
- -11.63%
News
marketbeat.com uniQure Q3 Earnings Call Highlights uniQure NASDAQ: QURE said the FDA has accepted its Biologics License Application for AMT-130, an investigational treatment for Huntington's disease, and granted the application Priority Review with a…
seekingalpha.com uniQure N.V. (QURE) Q3 2026 Earnings Call Transcript uniQure N.V. (QURE) Q3 2026 Earnings Call Transcript
zacks.com uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates uniQure (QURE) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to a loss of $1.38 per share a year ago.
benzinga.com uniQure Q3 2026 Earnings Call Transcript uniQure (NASDAQ:QURE) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com uniQure Q3 EPS $(0.88) Beats $(0.92) Estimate, Sales $5.200M Miss $6.178M Estimate uniQure (NASDAQ:QURE) reported quarterly losses of $(0.88) per share which beat the analyst consensus estimate of $(0.92) by 4.35 percent. This is a 36.23 percent increase over losses of $(1.38) per…
globenewswire.com uniQure Announces Third Quarter 2026 Financial Results and Provides Company Update ~ FDA granted priority review of BLA for ifezuntirgene inilparvovec (AMT-130) in Huntington's disease; PDUFA target action date of May 1, 2027 ~
seekingalpha.com uniQure: The Market May Be Misreading The AMT-130 Four-Year Data (Rating Upgrade) uniQure's stock has come under significant pressure again after the company reported mixed 4-year AMT-130 data. While measurement noise and control bias likely explain much of the disappointing…
benzinga.com FDA Pushes uniQure Huntington Therapy Forward, Analyst Brushes Off Softening Signals The U.S. Food and Drug Administration has accepted uniQure NV's (NASDAQ:QURE) Biologics License Application (BLA) for ifezuntirgene inilparvovec, an investigational gene therapy for Huntington's…
benzinga.com FDA Pushes uniQure Huntington Therapy Forward, Analyst Brushes Off Softening Signals FDA grants Priority Review to uniQure for its Huntington's gene therapy, setting a PDUFA target date of May 1, 2027.
globenewswire.com uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington's Disease ~ FDA sets PDUFA target action date of May 1, 2027 ~ ~ If approved, ifezuntirgene inilparvovec will be the world's first disease-modifying treatment for Huntington's disease ~ LEXINGTON, Mass. and…
zacks.com 3 Promising Genomics Stocks to Add to Your Portfolio Now Genomics and synthetic biology are transforming healthcare through precision medicine and gene editing, putting ILMN, QURE and TXG in focus as the markets expand.
benzinga.com Barclays Downgrades uniQure to Equal-Weight, Lowers Price Target to $28 Barclays analyst Eliana Merle downgrades uniQure (NASDAQ:QURE) from Overweight to Equal-Weight and lowers the price target from $60 to $28.
benzinga.com Hewlett Packard Enterprise, Capital Bancorp, FormFactor And Other Big Stocks Moving Higher On Wednesday U.S. stocks rose as Nasdaq gained 100+ points; HPE jumped 5.1% on stronger networking guidance and a Vultr AI rack order.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Stablecoin Development (AMEX:SDEV) stock increased by 121.6% to $3.48 during Tuesday's regular session. The market value of their outstanding shares is at $42.5 million. Iovance…
benzinga.com Crude Oil Down 1%; US Job Openings Fall In August U.S. stocks fell as job openings declined; oil slid and gold rose. BKYI doubled, SSTI surged, while NIVF plunged 77% and QURE fell 37%.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 26.8% to $0.32 during Tuesday's pre-market session. The company's market cap stands at $1.3 million. Summit Therapeutics (NASDAQ:SMMT) stock…
benzinga.com 9 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's after-market session. The market value of their outstanding shares is at $297.1 million. uniQure…
benzinga.com Backblaze, Infleqtion, Zeta Global And Other Big Stocks Moving Higher On Tuesday Dow Jones index fell 200+ points on Monday. Backblaze Inc rose 30.4% after $335M data storage deal with CoreWeave Inc. Other stocks also gained.
benzinga.com Jabil Posts Upbeat Q3 Results, Joins Uniqure, Braiin And Other Big Stocks Moving Higher On Wednesday U.S. stocks rose, with the Dow Jones gaining 200 points on Wed. Jabil Inc (JBL) shares surged 9.8% after beating earnings & revenue estimates. Other big gainers included QURE, CLPT, JLHL, BRAI, LZB,…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Earnings Scheduled For May 5, 2026 - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com This JM Smucker Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday Wall Street analysts upgraded Uniqure NV, Apyx Medical Inc, J M Smucker Co, and VTEX with raised price targets. See analyst ratings page.
benzinga.com 10 Health Care Stocks Moving In Monday's Pre-Market Session - benzinga.com Earnings Scheduled For March 2, 2026
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket 
benzinga.com Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com Earnings Scheduled For November 10, 2025 
benzinga.com Earnings Scheduled For July 29, 2025 
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 164 companies achieved new lows for the year.
benzinga.com Stocks Which Set New 52-Week High Yesterday, August 29th